We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App

Chinese COVID-19 Diagnostic Test Delivers Accurate Results in 40 Minutes Without Instrument for Less Than 70 Cents

By LabMedica International staff writers
Posted on 31 Aug 2020
Print article
Chinese researchers have developed a rapid CRISPR-based diagnostic for COVID-19 that delivers accurate results without the need for sophisticated equipment.

Researchers from the Xuzhou Medical University (Xuzhou, Jiangsu, China) harnessed the unique collateral activity of programmable CRISPR/Cas13a to develop CRISPR-COVID, a rapid and sensitive diagnostic for SARS-CoV-2 infection, and compared it to sequencing-based metagenomic and RT-PCR-based assays in a clinical cohort. CRISPR-COVID demonstrated a sensitivity level of near single copy and was highly specific without cross reacting to related pathogens. According to researchers, their study demonstrated that their CRISPR-based assay for COVID-19 offered shorter turn-around time and great diagnostic value, even in under-resourced settings without the need of thermal cyclers.

CRISPR-COVID takes only 40 minutes and requires no sophisticated thermo-cyclers, providing a valuable alternative to the conventional RT–PCR assay to circumvent the bottlenecks in assay turnaround time, equipment and reagent supplies for COVID-19 testing. The team noted that at research scale, the material costs of a CRISPR-COVID were less than USD 3.5, which could be dramatically reduced at production scale to less than 70 cents, making CRISPR-COVID a competitive alternative not only technologically but also financially.

Related Links:
Xuzhou Medical University

Print article



view channel
Image: An enzyme-linked immunosorbent assay for mannose-binding lectin found that this molecule is associated with coagulopathy in severe COVID-19 patients (Photo courtesy of Getty Images).

Mannose-Binding Lectin Associated with Coagulopathy in Severe COVID-19

The ongoing COVID-19 pandemic has caused significant morbidity and mortality worldwide, as well as profound effects on society. COVID-19 patients have an increased risk of thromboembolic (TE) complications,... Read more

Industry News

view channel

2020 AACC Annual Scientific Meeting & Clinical Lab Expo to Be an All Virtual Event Due to Coronavirus Pandemic

The American Association for Clinical Chemistry (AACC Washington, DC, USA) has decided to hold the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo as a virtual event, rather than as a live... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.